Developments in Purification Methods for Obtaining and Evaluation of Collagen Derived Endogenous Angioinhibitors

Citation

Gunda, V., Verma, R. K., Pawar, S. C., & Sudhakar, Y. A. (2014). Developments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitors. Protein Expression and Purification, 94, 46-52. doi: 10.1016/j.pep.2013.10.021

Abstract

Collagen constitutes one of the vital components of the basement membrane scaffolds. Non-collagenous domains (NC1) derived from collagens exhibit potent anti-angiogenic properties, thus attaining significance in regulation of angiogenesis promoted diseases. Individual NC1 domains essential for anti-angiogenic evaluations are generally obtained through purification of individual non-collagenous domains, which have undergone steady developments for enhancing the yields, purpose of biological evaluations and solubility based on the nature of different NC1 domains. This review focuses on the method developments in obtaining biologically active NC1 domains and for specific evaluations in different scenarios.


Read more from SRI

  • A rendering of the Parker Solar Probe inside the sun's corona.

    Parker Solar Probe: Our closest look at the sun

    SRI imaging technology supports a record-shattering NASA mission.

  • A photo of Mary Wagner

    Recognizing the life and work of Mary Wagner 

    A cherished SRI colleague and globally respected leader in education research, Mary Wagner leaves behind an extraordinary legacy of groundbreaking work supporting children and youth with disabilities and their families.

  • Testing XRGo in a robotics laboratory

    Robots in the cleanroom

    A global health leader is exploring how SRI’s robotic telemanipulation technology can enhance pharmaceutical manufacturing.